207 related articles for article (PubMed ID: 23082052)
1. Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas.
Hosono K; Yamada E; Endo H; Takahashi H; Inamori M; Hippo Y; Nakagama H; Nakajima A
World J Gastroenterol; 2012 Oct; 18(38):5360-8. PubMed ID: 23082052
[TBL] [Abstract][Full Text] [Related]
2. Chronological changes in circulating levels of soluble tumor necrosis factor receptors 1 and 2 in rats with carbon tetrachloride-induced liver injury.
Ijiri Y; Kato R; Sadamatsu M; Takano M; Okada Y; Tanaka K; Hayashi T
Toxicology; 2014 Feb; 316():55-60. PubMed ID: 24389507
[TBL] [Abstract][Full Text] [Related]
3. Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) Study.
Marti CN; Khan H; Mann DL; Georgiopoulou VV; Bibbins-Domingo K; Harris T; Koster A; Newman A; Kritchevsky SB; Kalogeropoulos AP; Butler J;
Circ Heart Fail; 2014 Jan; 7(1):5-11. PubMed ID: 24323631
[TBL] [Abstract][Full Text] [Related]
4. The role of tumor necrosis factor-α and TNF-α receptors in cerebral arteries following cerebral ischemia in rat.
Maddahi A; Kruse LS; Chen QW; Edvinsson L
J Neuroinflammation; 2011 Aug; 8():107. PubMed ID: 21871121
[TBL] [Abstract][Full Text] [Related]
5. Correlation of higher levels of soluble TNF-R1 with a shorter survival, independent of age, in recurrent glioblastoma.
Ahluwalia MS; Bou-Anak S; Burgett ME; Sarmey N; Khosla D; Dahiya S; Weil RJ; Bae E; Huang P; McGraw M; Grove LM; Olman MA; Prayson RA; Suh JH; Gillespie GY; Barnholtz-Sloan J; Nowacki AS; Barnett GH; Gladson CL
J Neurooncol; 2017 Feb; 131(3):449-458. PubMed ID: 27858267
[TBL] [Abstract][Full Text] [Related]
6. [Changes in concentrations of tumor necrosis factor TNF and its soluble receptors type 1 (sTNF-r1) and type 2 (sTNF-R2) in serum of patients with ST-segment elevation myocardial infarction].
Mielczarek-Palacz A; Sikora J; Kondera-Anasz Z; Smycz M
Wiad Lek; 2011; 64(2):71-4. PubMed ID: 22026268
[TBL] [Abstract][Full Text] [Related]
7. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients.
Ohya M; Taniguchi A; Fukushima M; Nakai Y; Kawasaki Y; Nagasaka S; Kuroe A; Taki Y; Yoshii S; Hosokawa M; Inagaki N; Seino Y
Metabolism; 2005 Oct; 54(10):1297-301. PubMed ID: 16154427
[TBL] [Abstract][Full Text] [Related]
8. Circulating TNF receptor 2 is closely associated with the kidney function in non-diabetic Japanese subjects.
Kurashina T; Nagasaka S; Watanabe N; Yabe D; Sugi N; Nin K; Hosokawa M; Nomura Y; Fukushima M; Nakai Y; Nishimura F; Taniguchi A
J Atheroscler Thromb; 2014; 21(7):730-8. PubMed ID: 24717758
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory cytokine activation is linked to apoptotic mediator, soluble Fas level in patients with chronic heart failure.
Kinugawa T; Kato M; Yamamoto K; Hisatome I; Nohara R
Int Heart J; 2012; 53(3):182-6. PubMed ID: 22790687
[TBL] [Abstract][Full Text] [Related]
10. The effect of intra-articular injection of different concentrations of ozone on the level of TNF-α, TNF-R1, and TNF-R2 in rats with rheumatoid arthritis.
Chen H; Yu B; Lu C; Lin Q
Rheumatol Int; 2013 May; 33(5):1223-7. PubMed ID: 23052485
[TBL] [Abstract][Full Text] [Related]
11. Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women.
Song M; Mehta RS; Wu K; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
Cancer Prev Res (Phila); 2016 Jan; 9(1):27-34. PubMed ID: 26511487
[TBL] [Abstract][Full Text] [Related]
12. Serial measurement of the circulating levels of tumour necrosis factor and its soluble receptors 1 and 2 for monitoring leprosy patients during multidrug treatment.
Costa RD; Mendonça VA; Soriani FM; Lyon S; Penido RA; Costa AM; Costa MD; Terra Fde S; Teixeira MM; Antunes CM; Teixeira AL
Mem Inst Oswaldo Cruz; 2013 Dec; 108(8):1051-6. PubMed ID: 24402158
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of tumor necrosis factor receptors 1 and 2 of the goldfish (Carassius aurutus L.).
Grayfer L; Belosevic M
Mol Immunol; 2009 Jul; 46(11-12):2190-9. PubMed ID: 19446337
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of C-reactive protein, interleukin-6 and tumor necrosis factor-α and risk of colorectal adenomas: a meta-analysis.
Zhang X; Liu S; Zhou Y
Oncotarget; 2016 Sep; 7(39):64371-64379. PubMed ID: 27608842
[TBL] [Abstract][Full Text] [Related]
15. Effects of treatment on soluble tumour necrosis factor receptor type 1 and 2 in chronic periodontitis.
Ikezawa-Suzuki I; Shimada Y; Tai H; Komatsu Y; Tanaka A; Yoshie H
J Clin Periodontol; 2008 Nov; 35(11):961-8. PubMed ID: 18823344
[TBL] [Abstract][Full Text] [Related]
16. Colitogenic role of tumour necrosis factor (TNF) receptors in trinitrobenzene sulphonic acid colitis: TNF-R1 ablation does not affect systemic inflammatory response.
Yang Y; Wang H; Dou Y; Wang Y; Han G; Wang R; Wang L; Guo R; Xiao H; Li X; Shen B; Shi Y; Chen G; Li Y
Clin Exp Immunol; 2011 Sep; 165(3):372-82. PubMed ID: 21668898
[TBL] [Abstract][Full Text] [Related]
17. The role of tumour necrosis factor alpha and soluble tumour necrosis factor alpha receptors in the symptomatology of schizophrenia.
Turhan L; Batmaz S; Kocbiyik S; Soygur AH
Nord J Psychiatry; 2016 Jul; 70(5):342-50. PubMed ID: 26754110
[TBL] [Abstract][Full Text] [Related]
18. Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma.
Goto N; Tsurumi H; Takemura M; Hara T; Sawada M; Kasahara S; Kanemura N; Yamada T; Shimizu M; Takahashi T; Tomita E; Seishima M; Takami T; Moriwaki H
Eur J Haematol; 2006 Sep; 77(3):217-25. PubMed ID: 16856931
[TBL] [Abstract][Full Text] [Related]
19. Systemic soluble tumor necrosis factor receptors 1 and 2 are associated with severity of diabetic retinopathy in Hispanics.
Kuo JZ; Guo X; Klein R; Klein BE; Cui J; Rotter JI; Ipp E; Chen YD
Ophthalmology; 2012 May; 119(5):1041-6. PubMed ID: 22330960
[TBL] [Abstract][Full Text] [Related]
20. Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis.
Shimizu T; Tomita Y; Son K; Nishinarita S; Sawada S; Horie T
Clin Rheumatol; 2000; 19(5):352-9. PubMed ID: 11055823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
